CN Stock MarketDetailed Quotes

600721 Xinjiang Bai Hua Cun Pharma Tech

Watchlist
  • 7.42
  • +0.02+0.27%
Trading Nov 15 11:25 CST
2.84BMarket Cap148.40P/E (TTM)

About Xinjiang Bai Hua Cun Pharma Tech Company

The company started in 1959 and was listed on the Shanghai Stock Exchange in 1996. It is mainly engaged in pharmaceutical research and development, clinical testing, testing and analysis, and commercial properties. It includes a total of 12 subsidiary companies, including Warwick Pharmaceuticals, which mainly focuses on pharmaceutical research and development, Lihua Biotech, which mainly focuses on clinical trials, Simmersberg, which focuses on analytical testing business, and commercial property management. The company's main business covers early discovery and screening of new drugs, drug CMC development, clinical trials, registration, BE/PK biological sample analysis and pharmaceutical testing services, clinical SMO and data services, MAH services, API and intermediate technology services. Corporate honors: “Market founders pay for designated markets first”; in 2004, it was rated as the 2003-2005 AAA Honest Enterprise by the Urumqi Municipal People's Government, etc.

Company Profile

Short Name-A百花医药
Symbol-A600721
Company NameXinjiang Bai Hua Cun Pharma Tech Co.,Ltd
Listing DateJun 26, 1996
Issue Price4.20
Shares Offered30.00M share(s)
FoundedJun 21, 1996
Listed ExchangeSH Stock Exchange
Legal Representativecaihong zheng
General Managerhui huang
Secretaryqinqin zhao
Accounting FirmSigma Certified Public Accountants (Special General Partnership)
Securities Representativelei meng
Legal CounselXinjiang Xinghe Law Firm
Employees759
Phone0991-2356600
Office AddressNo. 1, South Alley, Zhongshan Road, Tianshan District, Urumqi, Xinjiang
Zip Code830002
Registered AddressNo. 3, R&D Office Building, No. 699, Weiliu West Street, East Industrial Park, Wujiaqu, Xinjiang
Fax0991-2356601
Emailbhc@xjbhc.org
Business License650000040000152
BusinessImport and export of general goods and technology; border microtrade; energy investment and sales; sales of minerals, building materials and chemical products, machinery and equipment, hardware and electronic products, agricultural, animal husbandry products, food, beverages and tobacco products, textiles, clothing and household goods; trade brokerage and agency; warehousing; leasing; sports; business services; software and information technology services; other wholesale industries; integrated retail; market development and construction; advertising management; car leasing; parking services; technical services, technology development, technical consulting, technology exchange, technology transfer, technology promotion; medical research and testing; medical research and testing Development; biochemical product technology research and development; chemical product production (excluding licensed chemical products); chemical product sales (excluding licensed chemical products); pharmaceutical production; drug contract production; veterinary drug management; Class I medical device sales; Class III medical device management; data processing services; conference and exhibition services (projects requiring approval according to law, business activities can only be carried out after approval by relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • caihong zheng
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Audit Committee Member
  • 879.90K
  • zhengtian lv
  • Directors, Executive Deputy General Manager, Member of the Remuneration and Assessment Committee, Strategy Committee Member
  • 760.00K
  • yan xia
  • Directors, Deputy General Manager, Strategy Committee Member
  • --
  • jianbin sun
  • Directors, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • --
  • peixiang jiao
  • Directors, Strategy Committee Member
  • --
  • xiaoli ma
  • Directors, Nomination Committee Members
  • --
  • hui huang
  • Directors, Rotating General Manager, Strategy Committee Member
  • 1.30M
  • wenbao li
  • Independent Directors, Member of the Remuneration and Assessment Committee, Strategy Committee Member
  • 500.00K
  • li gu
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • 5.60K
  • xingyu lu
  • Independent Directors, Strategy Committee Member, Audit Committee Member, Nomination Committee Members
  • 80.00K
  • qunwei lu
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
  • --
  • qinqin zhao
  • Board Secretary, Assistant to the General Manager
  • 400.00K
  • lei meng
  • Securities Affairs Representative
  • 102.50K
  • bin ma
  • Chairman of the Supervisory Board, Auditors
  • --
  • jianwei ma
  • Auditors
  • --
  • ziyun cai
  • Chief Financial Officer
  • 529.90K
  • min tang
  • Employee Supervisors
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data